Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.

Sung Hee ChoiJay Thomas MyersSuzanne Louise TomchuckMelissa BonnerSaada EidDaniel Tyler KingsleyKristen Ashley VanHeystSeong-Jin KimByung-Gyu KimAlex Yee-Chen Huang

Published in: Cancer communications (London, England) (2024)

Keyphrases

transforming growth factor
epithelial mesenchymal transition
signaling pathway
binding protein